Sultiame

Sultiame.svg

Sultiame is a sulfonamide anticonvulsant drug primarily used in the treatment of epilepsy. It is known for its effectiveness in managing seizures and is often used as an adjunctive therapy in patients who do not respond adequately to other antiepileptic drugs.

Pharmacology

Sultiame works by inhibiting the enzyme carbonic anhydrase, which plays a role in the regulation of neuronal excitability. This inhibition leads to a reduction in the frequency and severity of seizures. The exact mechanism by which sultiame exerts its anticonvulsant effects is not fully understood, but it is believed to involve the modulation of ion channels and neurotransmitter systems.

Indications

Sultiame is indicated for the treatment of various types of epilepsy, including:

• Focal seizures
• Generalized seizures
• Absence seizures

Side Effects

Common side effects of sultiame include:

• Dizziness
• Fatigue
• Nausea
• Headache

Less common but more serious side effects may include:

• Allergic reactions
• Blood dyscrasias
• Liver toxicity

Dosage and Administration

The dosage of sultiame varies depending on the patient's age, weight, and the severity of the condition. It is typically administered orally in the form of tablets. The dosage is usually started at a low level and gradually increased to minimize the risk of side effects.

Contraindications

Sultiame is contraindicated in patients with:

• Hypersensitivity to sulfonamides
• Severe renal impairment
• Severe hepatic impairment

Interactions

Sultiame may interact with other medications, including:

• Other antiepileptic drugs
• Diuretics
• Antihypertensive drugs

Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

History

Sultiame was first introduced in the 1960s and has since been used in various countries for the management of epilepsy. It is not as widely used as some other antiepileptic drugs, but it remains an important option for patients with refractory epilepsy.

Research

Ongoing research is exploring the potential of sultiame in the treatment of other neurological conditions and its long-term safety profile.

See Also

• Epilepsy
• Anticonvulsant
• Seizure
• Carbonic anhydrase inhibitor

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian